entertainment -WSS

entertainment

author：leisure time 2025-09-30 00:03:02 - browse：95436

Illustration of the U.S. made of blue and white lines. -- health tech coverage from STAT — Adobe

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence tools designed for use in health care.

The nonprofit will establish the laboratories at Mayo Clinic, Duke, Stanford, and other major universities and institutions around the country. Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted. The labs are expected to begin operating within the next few months.

The nonprofit’s launch, unfolding amid rapid innovation and investment in AI, is an attempt at industry self-policing as increasingly powerful — and opaque — algorithmic models begin making their way into medical settings. It is being formed by a group known as the Coalition for Health AI, whose leadership includes technology experts at the academic hospitals that would host the testing labs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Texas board proposes rules on abortion law emergency exemption

explore

hotspot

focus

WSS

Methadone treatment changes are coming. Do they go far enough?

Readout Newsletter: Illumina, CRISPR, Regeneron

Pregnancy ages women, but effects reverse after delivery

U.K. researchers warn about biases in medical devices, algorithms

5 to watch: Tech startups trying to solve health care's staffing crisis

Stop the failed accountable care organization experiment

knowledge

entertainment

leisure time

Continuity nursing helped my family in our darkest PICU moments

With Wegovy coverage, Medicare patients may face high costs

Cancer drug shortages should be causing more outrage

Gene editing the human germline: What are the risks?

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Illumina, CRISPR, Regeneron

Trump demands the U.S. pay no more for drugs than other countries … again

Biotech investment managers search for lucrative opportunities

Wildfire smoke exposes gaps in outdoor worker protections

6 surprising facts about sugar

focus

Cancer, immunology, HIV research ensnared in fetal tissue politics

Orchard's therapy for neuron disease in children wins FDA approval

Readout Newsletter: Illumina, CRISPR, Regeneron

Methadone treatment changes are coming. Do they go far enough?

SCOTUS questions limit to govt efforts to fight misinformation

Health AI adoption puts security, privacy startups on investors' radar

explore

hotspot

focus

hotspot